Age-related macular degeneration
Age-related macular degeneration is a leading cause of visual impairment and severe vision
loss. Clinically, it is classified as early-stage (medium-sized drusen and retinal pigmentary …
loss. Clinically, it is classified as early-stage (medium-sized drusen and retinal pigmentary …
Deep learning in ophthalmology: the technical and clinical considerations
The advent of computer graphic processing units, improvement in mathematical models and
availability of big data has allowed artificial intelligence (AI) using machine learning (ML) …
availability of big data has allowed artificial intelligence (AI) using machine learning (ML) …
Guidelines for the management of diabetic macular edema by the European Society of Retina Specialists (EURETINA)
U Schmidt-Erfurth, J Garcia-Arumi, F Bandello… - …, 2017 - karger.com
Diabetic retinal disease is envisioned to become the plague of the coming decades with a
steep increase of worldwide diabetes incidence followed by a substantial rise in retinal …
steep increase of worldwide diabetes incidence followed by a substantial rise in retinal …
Recent developments in age-related macular degeneration: a review
WM Al-Zamil, SA Yassin - Clinical interventions in aging, 2017 - Taylor & Francis
Background Visual impairment in elderly people is a considerable health problem that
significantly affects quality of life of millions worldwide. The magnitude of this issue is …
significantly affects quality of life of millions worldwide. The magnitude of this issue is …
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial
JA Wells, AR Glassman, AR Ayala, LM Jampol… - Ophthalmology, 2016 - Elsevier
Purpose To provide 2-year results comparing anti–vascular endothelial growth factor
(VEGF) agents for center-involved diabetic macular edema (DME) using a standardized …
(VEGF) agents for center-involved diabetic macular edema (DME) using a standardized …
The progress in understanding and treatment of diabetic retinopathy
Diabetic retinopathy is the most frequently occurring complication of diabetes mellitus and
remains a leading cause of vision loss globally. Its aetiology and pathology have been …
remains a leading cause of vision loss globally. Its aetiology and pathology have been …
Five-year outcomes with anti–vascular endothelial growth factor treatment of neovascular age-related macular degeneration: the comparison of age-related macular …
MG Maguire, DF Martin, G Ying, GJ Jaffe, E Daniel… - Ophthalmology, 2016 - Elsevier
Purpose To describe outcomes 5 years after initiating treatment with bevacizumab or
ranibizumab for neovascular age-related macular degeneration (AMD). Design Cohort …
ranibizumab for neovascular age-related macular degeneration (AMD). Design Cohort …
Reticular pseudodrusen: a critical phenotype in age-related macular degeneration
Reticular pseudodrusen (RPD), or subretinal drusenoid deposits (SDD), refer to distinct
lesions that occur in the subretinal space. Over the past three decades, their presence in …
lesions that occur in the subretinal space. Over the past three decades, their presence in …
Age-related macular degeneration preferred practice pattern®
Background: Age-related macular degeneration is a leading cause of severe, irreversible
vision impairment in developed countries. The primary risk factors for the development of …
vision impairment in developed countries. The primary risk factors for the development of …
Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA)
Age-related macular degeneration (AMD) is still referred to as the leading cause of severe
and irreversible visual loss world-wide. The disease has a profound effect on quality of life of …
and irreversible visual loss world-wide. The disease has a profound effect on quality of life of …